Skip to main content
Top
Published in: Current Anesthesiology Reports 2/2022

21-03-2022 | Blood Management (KA Tanaka, Section Editor)

Von Willebrand Factor and Platelet Aggregation: from Bench to Clinical Practice

Authors: Katrina J. Ashworth, Kimberly A. Thomas, Susan M. Shea

Published in: Current Anesthesiology Reports | Issue 2/2022

Login to get access

Abstract

Purpose of Review

This review describes von Willebrand factor (VWF)-mediated platelet function in inherited and acquired bleeding disorders, and current and novel approaches from bench to clinical practice used to perform research, diagnose, and treat bleeding disorders.

Recent Findings

Patients can present with either qualitative or quantitative defects in VWF and/or platelets, which can be inherited or acquired. Understanding the structure–function relationships of VWF and platelets has led to clinically useful classification and treatment of coagulopathy. However, current bench and clinical assays can be time-consuming and have limitations that preclude assessment of important mechanistic drivers, including physiologically relevant flow conditions pertinent to VWF-mediated platelet function.

Summary

The purpose of this review is to discuss current and traditional laboratory-based assessment of VWF-mediated platelet function and the translation to clinical practice with specific focus on patient bleeding risks and the tools available for their management.
Literature
7.
go back to reference Foster PA, Fulcher CA, Marti T, Titani K, Zimmerman TS. A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor. J Biol Chem. 1987;262(18):8443–6.CrossRef Foster PA, Fulcher CA, Marti T, Titani K, Zimmerman TS. A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor. J Biol Chem. 1987;262(18):8443–6.CrossRef
8.
go back to reference Endenburg SC, Hantgan RR, Lindeboom-Blokzijl L, Lankhof H, Jerome WG, Lewis JC, et al. On the role of von Willebrand factor in promoting platelet adhesion to fibrin in flowing blood. Blood. 1995;86(11):4158–65.CrossRef Endenburg SC, Hantgan RR, Lindeboom-Blokzijl L, Lankhof H, Jerome WG, Lewis JC, et al. On the role of von Willebrand factor in promoting platelet adhesion to fibrin in flowing blood. Blood. 1995;86(11):4158–65.CrossRef
16.
go back to reference da Silva ML, von Cutler DF. Willebrand factor multimerization and the polarity of secretory pathways in endothelial cells. Blood. 2016;128(2):277–85.CrossRef da Silva ML, von Cutler DF. Willebrand factor multimerization and the polarity of secretory pathways in endothelial cells. Blood. 2016;128(2):277–85.CrossRef
19.
go back to reference Gardiner EE, Andrews RK. Platelets in Thrombotic and Non-Thrombotic Disorders. Cham, Switzerland: Springer; 2017. Gardiner EE, Andrews RK. Platelets in Thrombotic and Non-Thrombotic Disorders. Cham, Switzerland: Springer; 2017.
21.
go back to reference Lankhof H, van Hoeij M, Schiphorst ME, Bracke M, Wu YP, Ijsseldijk MJ, et al. A3 domain is essential for interaction of von Willebrand factor with collagen type III. Thromb Haemost. 1996;75(6):950–8.CrossRef Lankhof H, van Hoeij M, Schiphorst ME, Bracke M, Wu YP, Ijsseldijk MJ, et al. A3 domain is essential for interaction of von Willebrand factor with collagen type III. Thromb Haemost. 1996;75(6):950–8.CrossRef
40.
go back to reference Martin SE, Marder VJ, Francis CW, Barlow GH. Structural studies of the functional heterogeneity of von Willebrand protein polymers. Blood. 1981;57(2):313–23.CrossRef Martin SE, Marder VJ, Francis CW, Barlow GH. Structural studies of the functional heterogeneity of von Willebrand protein polymers. Blood. 1981;57(2):313–23.CrossRef
47.
go back to reference Mazurier C, Ribba AS, Gaucher C, Meyer D. Molecular genetics of von Willebrand disease. Ann Genet. 1998;41(1):34–43.PubMed Mazurier C, Ribba AS, Gaucher C, Meyer D. Molecular genetics of von Willebrand disease. Ann Genet. 1998;41(1):34–43.PubMed
49.
go back to reference Federici AB 2003 The factor VIII/von Willebrand factor complex: basic and clinical issues. Haematologica. 88(6):EREP02-EREP. https://doi.org/10.3324//x Federici AB 2003 The factor VIII/von Willebrand factor complex: basic and clinical issues. Haematologica. 88(6):EREP02-EREP. https://​doi.​org/​10.​3324/​/​x
62.
go back to reference Scharf RE. Drugs that Affect Platelet Function. Semin Thromb Hemost. 2012;38(08):865–83.CrossRef Scharf RE. Drugs that Affect Platelet Function. Semin Thromb Hemost. 2012;38(08):865–83.CrossRef
72.
go back to reference Slusarz MJ, Slusarz R, Ciarkowski J. Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: molecular dynamics simulation of the agonist-bound state in the membrane-aqueous system. Biopolymers. 2006;81(5):321–38. https://doi.org/10.1002/bip.20420.CrossRefPubMed Slusarz MJ, Slusarz R, Ciarkowski J. Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: molecular dynamics simulation of the agonist-bound state in the membrane-aqueous system. Biopolymers. 2006;81(5):321–38. https://​doi.​org/​10.​1002/​bip.​20420.CrossRefPubMed
81.
go back to reference Chassot PG, Marcucci C, Delabays A, Spahn DR. Perioperative antiplatelet therapy. Am Fam Physician. 2010;82(12):1484–9.PubMed Chassot PG, Marcucci C, Delabays A, Spahn DR. Perioperative antiplatelet therapy. Am Fam Physician. 2010;82(12):1484–9.PubMed
83.
88.
go back to reference Callaghan S, Cai T, McCafferty C, Van Den Helm S, Horton S, MacLaren G et al 2020 Adsorption of blood components to extracorporeal membrane oxygenation (ECMO) surfaces in humans: a systematic review. J Clin Med. 9(10). https://doi.org/10.3390/jcm9103272. Callaghan S, Cai T, McCafferty C, Van Den Helm S, Horton S, MacLaren G et al 2020 Adsorption of blood components to extracorporeal membrane oxygenation (ECMO) surfaces in humans: a systematic review. J Clin Med. 9(10). https://​doi.​org/​10.​3390/​jcm9103272.
99.
go back to reference Weinstein M, Ware JA, Troll J, Salzman E. Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood. 1988;71(6):1648–55.CrossRef Weinstein M, Ware JA, Troll J, Salzman E. Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood. 1988;71(6):1648–55.CrossRef
101.
go back to reference Kondo C, Tanaka K, Takagi K, Shimono T, Shinpo H, Yada I, et al. Platelet dysfunction during cardiopulmonary bypass surgery. With special reference to platelet membrane glycoproteins. ASAIO J. 1993;39(3):M550-3.PubMed Kondo C, Tanaka K, Takagi K, Shimono T, Shinpo H, Yada I, et al. Platelet dysfunction during cardiopulmonary bypass surgery. With special reference to platelet membrane glycoproteins. ASAIO J. 1993;39(3):M550-3.PubMed
110.•
go back to reference Dyer MR, Plautz WE, Ragni MV, Alexander W, Haldeman S, Sperry JL, et al. Traumatic injury results in prolonged circulation of ultralarge von Willebrand factor and a reduction in ADAMTS13 activity. Transfusion. 2020;60(6):1308–18. https://doi.org/10.1111/trf.15856. Dyer et al. found that VWF levels increase and ADATMS13 activity concurrently decreases in trauma patients at admission and 24 hours post-admission, and ultralarge VWF were elevated at the same timepoints. ADAMTS13 activity also predicted coagulopathy in these patients.CrossRefPubMed Dyer MR, Plautz WE, Ragni MV, Alexander W, Haldeman S, Sperry JL, et al. Traumatic injury results in prolonged circulation of ultralarge von Willebrand factor and a reduction in ADAMTS13 activity. Transfusion. 2020;60(6):1308–18. https://​doi.​org/​10.​1111/​trf.​15856. Dyer et al. found that VWF levels increase and ADATMS13 activity concurrently decreases in trauma patients at admission and 24 hours post-admission, and ultralarge VWF were elevated at the same timepoints. ADAMTS13 activity also predicted coagulopathy in these patients.CrossRefPubMed
111.
go back to reference Insititute CLS 2008 H21-A5 collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays, 5th Edition. Fifth ed., 48. Insititute CLS 2008 H21-A5 collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays, 5th Edition. Fifth ed., 48.
117.••
go back to reference Karkouti K, Callum J, Wijeysundera DN, Rao V, Crowther M, Grocott HP, et al. Point-of-care hemostatic testing in cardiac surgery: a stepped-wedge clustered randomized controlled trial. Circulation. 2016;134(16):1152–62. https://doi.org/10.1161/CIRCULATIONAHA.116.023956. Karkouti et al. performed an RCT to compare 4-factor prothrombin complex concentrate (PCC) to frozen plasma use in cardiac surgery. Patients that received PCC had lower blood loss and fewer transfusions.CrossRefPubMed Karkouti K, Callum J, Wijeysundera DN, Rao V, Crowther M, Grocott HP, et al. Point-of-care hemostatic testing in cardiac surgery: a stepped-wedge clustered randomized controlled trial. Circulation. 2016;134(16):1152–62. https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​116.​023956. Karkouti et al. performed an RCT to compare 4-factor prothrombin complex concentrate (PCC) to frozen plasma use in cardiac surgery. Patients that received PCC had lower blood loss and fewer transfusions.CrossRefPubMed
120.
go back to reference Anaya R, Rodriguez M, Gil JM, Vilalta N, Merchan-Galvis A, Moral V et al 2021 Correlation between PlateletWorks((R)) and PFA-100((R)) for measuring platelet function before urgent surgery in patients with chronic antiplatelet therapy. J Clin Med. 10(2). https://doi.org/10.3390/jcm10020255. Anaya R, Rodriguez M, Gil JM, Vilalta N, Merchan-Galvis A, Moral V et al 2021 Correlation between PlateletWorks((R)) and PFA-100((R)) for measuring platelet function before urgent surgery in patients with chronic antiplatelet therapy. J Clin Med. 10(2). https://​doi.​org/​10.​3390/​jcm10020255.
125.
go back to reference Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib. Thromb Haemost. 1990;64(2):326–32.CrossRef Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib. Thromb Haemost. 1990;64(2):326–32.CrossRef
127.
138.
go back to reference Sikora J, Karczmarska-Wodzka A, Bugieda J, Sobczak P 2021 The use of total thrombus formation analysis system as a tool to assess platelet function in bleeding and thrombosis risk-a systematic review. Int J Mol Sci. 22(16). https://doi.org/10.3390/ijms22168605. Sikora J, Karczmarska-Wodzka A, Bugieda J, Sobczak P 2021 The use of total thrombus formation analysis system as a tool to assess platelet function in bleeding and thrombosis risk-a systematic review. Int J Mol Sci. 22(16). https://​doi.​org/​10.​3390/​ijms22168605.
139.••
go back to reference Ting LH, Feghhi S, Taparia N, Smith AO, Karchin A, Lim E, et al. Contractile forces in platelet aggregates under microfluidic shear gradients reflect platelet inhibition and bleeding risk. Nat Commun. 2019;10(1):1204. https://doi.org/10.1038/s41467-019-09150-9. Ting et al. test a microfluidic device that induces platelet aggregation onto arrays of block-post constructs, which was commercialized as the Stasys device. This study shows differences in force generation over time due to platelet inhibition as well as in a cardiology patient.CrossRefPubMedPubMedCentral Ting LH, Feghhi S, Taparia N, Smith AO, Karchin A, Lim E, et al. Contractile forces in platelet aggregates under microfluidic shear gradients reflect platelet inhibition and bleeding risk. Nat Commun. 2019;10(1):1204. https://​doi.​org/​10.​1038/​s41467-019-09150-9. Ting et al. test a microfluidic device that induces platelet aggregation onto arrays of block-post constructs, which was commercialized as the Stasys device. This study shows differences in force generation over time due to platelet inhibition as well as in a cardiology patient.CrossRefPubMedPubMedCentral
Metadata
Title
Von Willebrand Factor and Platelet Aggregation: from Bench to Clinical Practice
Authors
Katrina J. Ashworth
Kimberly A. Thomas
Susan M. Shea
Publication date
21-03-2022
Publisher
Springer US
Published in
Current Anesthesiology Reports / Issue 2/2022
Electronic ISSN: 2167-6275
DOI
https://doi.org/10.1007/s40140-022-00521-5

Other articles of this Issue 2/2022

Current Anesthesiology Reports 2/2022 Go to the issue

Anesthesia for Trauma (TE Grissom, Section Editor)

Regional Anesthesia for Trauma in the Emergency Department

ANESTHESIA FOR TRAUMA (TE GRISSOM, SECTION EDITOR)

Trauma and the Anesthesiologist: an International Perspective